Medicinal Chemistry

Research Frontiers in Poly-ADP-Ribose Polymerase Inhibitor Strategies

Development of selective PARP inhibitors with variable NAD+ binding modes to enhance synthetic lethality in homologous recombination-deficient cancers.

All Medicinal Chemistry PhD categories